MENU
IMA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ImageneBio (IMA) Ownership - Who owns ImageneBio?

ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
66.21M
P/E Ratio
N/A
Total Cash
117.21M
Projected Growth
N/A
Total Debt
2.42M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
10.39
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
IMA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details